EF 8AM Focussed Fund A Inc

Category GBP Flexible Allocation
star-filledstar-filledstar-filled
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

139.80p

arrow-up0.81p (+0.58%)

Fund Code

EIFAI

B9L4T62

GB00B9L4T627

Prices updated as at 26 Apr 2024
|
Prices in GBX
Investment objective
The objective of the fund is to achieve long-term capital growth. The Fund engages in global tactical asset allocation and at least 50% of the Fund’s assets will be invested in Exchange Traded Funds, including traditional closed-end funds and investment trusts. Whilst the majority of these are equity-based some also provide exposure to bond markets, currencies, commodities, listed private equity, infrastructure and real estate as well as hedge funds.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Annual charges

Product charges
1.98
0.10
No
-
0.00
0.00
Minimum investment25.00

Documents

Document nameDate postedDownload
Fund Provider FactSheet 31 Mar 2024pdf
Key Information Document / Technical Guide 12 Mar 2024pdf
Annual Reports 30 Dec 2023pdf
Interim Short Report 30 Dec 2023pdf
Annual Short Report 30 Jun 2023pdf
Please note that service charges will also apply. Read more about our fees.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.